Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 10, 2001

View Archived Issues

Affibody Raises US$28M For Programs In Antibody Mimics

EU Court Backs Biotechnology Patents, Dismisses Challenge

Biotechnica Trade Fair Draws Record Number Of Exhibitors

Gene Sequence Of Plague Agent Could Lead To New Therapies

Scottish Officials Devise Plan To Support Local Development

Other News To Note

Australian Company ACT Starts Vaccine Studies Against P53

Endocube Sets Out To Discover New Anti-Inflammatory Therapies

Biobank Aims To Help Biotech Start-Ups Take Root and Develop

Euro Commission Report Says GM Plants Show No New Risks

Germany Supports Another 7 Nanobiotechnology Projects

Microscience, Anadis Enter Deal Around STM Technology

SR Pharma Says Data Support Continued SRL172 Development

Synt:em, BLSI Collaborate To Optimize CNS Diagnostic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...